Precision Prescribing and Novel Treatment Promise to Resolve Unmet Needs in the Treatment of Major Depressive Disorder

Precision Prescribing and Novel Treatment Promise to Resolve Unmet Needs in the Treatment of Major Depressive Disorder

  • Question 1
  • Precision Prescribing and Novel Treatment Promise to Resolve Unmet Needs in the Treatment of Major Depressive Disorder
  • Question 2
  • Complete
True or false? Newer targeted therapies, such as intravenous (IV) N-methyl-D-aspartate ionotropic glutamatergic receptor modulators esketamine and rapastinel, have been shown to provide relief in patients with treatment-resistant major depressive disorder (MDD), with the onset of effect within 2 hours after infusion.